Logo image of BONE.CA

BORON ONE HOLDINGS INC (BONE.CA) Stock Fundamental Analysis

TSX-V:BONE - TSX Venture Exchange - CA10002E1060 - Common Stock - Currency: CAD

0.04  0 (0%)

Fundamental Rating

1

BONE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 806 industry peers in the Metals & Mining industry. BONE has a bad profitability rating. Also its financial health evaluation is rather negative. BONE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BONE had negative earnings in the past year.
In the past year BONE has reported a negative cash flow from operations.
In the past 5 years BONE always reported negative net income.
In the past 5 years BONE always reported negative operating cash flow.
BONE.CA Yearly Net Income VS EBIT VS OCF VS FCFBONE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500K -1M -1.5M -2M

1.2 Ratios

BONE's Return On Assets of -8.68% is fine compared to the rest of the industry. BONE outperforms 62.28% of its industry peers.
BONE's Return On Equity of -9.30% is fine compared to the rest of the industry. BONE outperforms 65.63% of its industry peers.
Industry RankSector Rank
ROA -8.68%
ROE -9.3%
ROIC N/A
ROA(3y)-9.45%
ROA(5y)-9.93%
ROE(3y)-10.09%
ROE(5y)-10.61%
ROIC(3y)N/A
ROIC(5y)N/A
BONE.CA Yearly ROA, ROE, ROICBONE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20

1.3 Margins

BONE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BONE.CA Yearly Profit, Operating, Gross MarginsBONE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, BONE has more shares outstanding
The number of shares outstanding for BONE has been increased compared to 5 years ago.
The debt/assets ratio for BONE is higher compared to a year ago.
BONE.CA Yearly Shares OutstandingBONE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BONE.CA Yearly Total Debt VS Total AssetsBONE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 3.65 indicates that BONE is not in any danger for bankruptcy at the moment.
BONE has a better Altman-Z score (3.65) than 61.66% of its industry peers.
BONE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
BONE has a Debt to Equity ratio of 0.01. This is comparable to the rest of the industry: BONE outperforms 49.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 3.65
ROIC/WACCN/A
WACCN/A
BONE.CA Yearly LT Debt VS Equity VS FCFBONE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M 10M

2.3 Liquidity

A Current Ratio of 0.12 indicates that BONE may have some problems paying its short term obligations.
BONE has a worse Current ratio (0.12) than 79.78% of its industry peers.
BONE has a Quick Ratio of 0.12. This is a bad value and indicates that BONE is not financially healthy enough and could expect problems in meeting its short term obligations.
BONE has a Quick ratio of 0.12. This is in the lower half of the industry: BONE underperforms 79.16% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
BONE.CA Yearly Current Assets VS Current LiabilitesBONE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for BONE have decreased strongly by -27.03% in the last year.
EPS 1Y (TTM)-27.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
BONE.CA Price Earnings VS Forward Price EarningsBONE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BONE.CA Per share dataBONE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02 0.03 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BONE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BORON ONE HOLDINGS INC

TSX-V:BONE (7/25/2025, 7:00:00 PM)

0.04

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.18%
Ins Owner ChangeN/A
Market Cap9.41M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.91
P/tB 0.91
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.68%
ROE -9.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-9.45%
ROA(5y)-9.93%
ROE(3y)-10.09%
ROE(5y)-10.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1578.23%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z 3.65
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1918.71%
Cap/Depr(5y)2211.22%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-66.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.7%
OCF growth 3YN/A
OCF growth 5YN/A